arrow
M

Milla E.L. Kuusisto

university of eastern finland hospital
H指数:9
被引数:262

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation

尽管T细胞/组织细胞富集型大B细胞淋巴瘤具有高风险疾病表现,但患者中枢神经系统复发的风险较低

2026-08-010
OAAI
Early venetoclax dose escalation at minimal residual disease progression may benefit selected acute myeloid leukaemia patients

早期在微小残留病进展时增加维奈克拉剂量可能使特定急性髓系白血病患者受益

2026-07-010
OAAI
Socioeconomic Status and Access to Treatment in Diffuse Large B-Cell Lymphoma

社会经济地位与弥漫性大B细胞淋巴瘤的治疗可及性

2026-05-100
OAAI
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma

症状到诊断的延长时间与弥漫性大B细胞淋巴瘤的不良无进展生存期相关

2025-11-230
OAAI
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
2022-12-1528
OAAI
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma
2017-07-1721
OAAI